OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES

This multicenter international retrospective analysis aimed to evaluate the efficacy and safety of subcutaneous alemtuzumab (ALZ) as an alternative immunosuppressive therapy for aplastic anemia (AA). The study included 57 with AA patients who received ALZ treatment in four centers in Brazil and the...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	AR Fonseca, CC Justino, VC Molla, PE Yamakawa, IB Rabelo, A Hill, L Arnold, R Kelly, M Griffin, T Munir, E Velloso, T Dalessandro, AM Risitano, P Scheinberg, A Kulasekararaj, C Arrais-Rodrigues
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2023-10-01
Schriftenreihe:	Hematology, Transfusion and Cell Therapy
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2531137923002900
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!